Search clinical trials for: depsipeptide
Total 27 results
-
Royal Marsden NHS Foundation TrustUnknown
-
National Cancer Institute (NCI)Completed
-
CelgeneCompletedPeripheral T-cell LymphomaUnited States, Spain, Germany, France, Czechia, Australia, Sweden, United Kingdom, Ukraine, Poland
-
CelgeneCelgene CorporationCompletedCutaneous T-cell LymphomaUnited States, France, Germany, Poland, Russian Federation, United Kingdom
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral Cancer
-
University of ChicagoNational Cancer Institute (NCI)WithdrawnOvarian CancerUnited States
-
National Cancer Institute (NCI)CompletedAdult Anaplastic Astrocytoma | Adult Anaplastic Oligodendroglioma | Adult Giant Cell Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain TumorUnited States
-
CelgeneTerminated
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)TerminatedMelanoma | Malignant Melanoma
-
Paddock Laboratories, Inc.CompletedHealthyUnited States
-
National Cancer Institute (NCI)TerminatedCarcinoma, Non-Small-Cell Lung | Esophageal Neoplasms | Mesothelioma | Carcinoma, Small CellUnited States
-
CelgeneCompletedPancreatic CancerUnited States
-
University of VirginiaRecruitingLymphoma, T-CellUnited States
-
Peter MacCallum Cancer Centre, AustraliaCelgene Corporation; Janssen-Cilag Ltd.UnknownMultiple MyelomaAustralia
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Celgene CorporationTerminatedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
Paddock Laboratories, Inc.Completed
-
National Cancer Institute (NCI)CompletedNon-Small-Cell Lung Carcinoma | Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura | Advanced Esophageal Cancers | Primary Small Cell Lung Cancers | Pleural MesotheliomasUnited States
-
National Cancer Institute (NCI)CompletedAlisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell LymphomasRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With... and other conditionsUnited States
-
National Cancer Institute (NCI)Celgene CorporationActive, not recruitingGlioma | Hematopoietic and Lymphoid Cell Neoplasm | Lymphoma | Recurrent Head and Neck Carcinoma | Recurrent Lung Carcinoma | Recurrent Renal Cell Carcinoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Pancreatic Carcinoma | Stage III Pancreatic Cancer... and other conditionsUnited States, Canada
-
Ohio State University Comprehensive Cancer CenterCelgene CorporationRecruitingCutaneous T-cell Lymphoma | Peripheral T-Cell Lymphoma | T-Prolymphocytic Leukemia | T-Large Granulocytic Leukemia | T-Lymphoblastic Leukemia/LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedAnaplastic Large Cell Lymphoma | Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Refractory Mature T-Cell and NK-Cell Non-Hodgkin LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Angioimmunoblastic T-Cell Lymphoma | Recurrent Mycosis Fungoides | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Angioimmunoblastic T-Cell Lymphoma | Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Refractory Mycosis Fungoides | Refractory Anaplastic... and other conditionsUnited States
-
Walter HanelActive, not recruitingRecurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Refractory Anaplastic Large Cell Lymphoma | T-Cell Non-Hodgkin Lymphoma | Refractory Primary Cutaneous T-Cell Non-Hodgkin... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMycosis Fungoides | Recurrent Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-Cell Lymphoma | Refractory Anaplastic Large Cell Lymphoma | Recurrent Anaplastic Large Cell Lymphoma | Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified | Recurrent Enteropathy-Associated... and other conditionsUnited States
-
Mayo ClinicNational Cancer Institute (NCI)SuspendedRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Recurrent Breast Carcinoma | Recurrent Mycosis Fungoides | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Stage IV Breast Cancer AJCC v6 and v7 | Breast Adenocarcinoma and other conditionsUnited States